Skip to main content
. 2021 Oct 11;11:20175. doi: 10.1038/s41598-021-99726-7

Table 6.

Multivariate logistic regression analysis of demographic, therapeutic, and histopathologic parameters between Groups 1 and 3.

Parameter B Sig Exp(B) 95% C.I. for EXP(B)
CEA (continuous) 0.052 0.006 1.053 1.015–1.093
Tumor size (cm) (continuous) 0.155 0.009 1.168 1.040–1.311
No NACT (ref.) 0.134 1
No response to NACT 22.897 0.999 8,788,932,664.350 0.000–
Partial response to NACT 0.842 0.021 2.320 1.137–4.734
Complete response to NACT − 0.396 0.707 0.673 0.086–5.296
ER-negative (ref.) 0.028 1
ER(+) − 0.632 0.086 0.531 0.258–1.094
ER(++) − 0.490 0.154 0.613 0.312–1.202
ER(+++) − 0.841 0.004 0.431 0.245–0.759
N0 (ref.) < 0.001 1
N1 0.200 0.521 1.221 0.663–2.249
N2 1.118 0.001 3.058 1.591–5.878
N3 1.291 < 0.001 3.635 1.790–7.379
No local recurrence (ref.) 0.052 1
Recurrence in the opposite breast 0.578 0.316 1.782 0.575–5.519
Locoregional recurrence 1.283 0.024 3.609 1.188–10.964
Constant − 2.736 < 0.001 0.065

NACT neoadjuvant chemotherapy, N nodal involvement.